🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📢 Calling all trainees considering #AdvHFTx cardiology! Will you be attending HFSA #ASM2024 in ATL? Drop by our HF fellowship program meet and greet and meet some of our faculty members! NM Cardiovascular Jane Wilcox, MD, MSc Yasmin Raza Faraz Sarah Chuzi, MD, MSc McGaw Medical Center of Northwestern University Details 👇🏾

1/ This guideline addresses evidence-based management strategies (including pharmacologic therapies, perioperative monitoring, and devices) for cardiovascular disease (CVD) and associated medical conditions.

Great article by NM Cardiovascular C4AI core faculty (and alumni of the AI fellowship) and colleagues on the challenges of data integration in the era of AI and wearables. Nice discussion of role of FHIR 🔥 and the need for better digital infrastructure. James D Thomas, MD

Thanks for the invitation to join the podcast live! Great discussion about #AI, #digitalhealth and consumer #tech. Heart Rhythm Society HRX Heart Rhythm TV Faraz NM Cardiovascular

From JAMA Cardiology: Deep learning (DL) has the potential to reshape the field of cardiovascular imaging (CVI). This review aims to demystify the methodology and application of DL to CVI. ja.ma/3AcnfCg

Faraz S. Ahmad, MD, MS (Faraz), kicked off day one of #AHA24 with a moderated poster session on the use of #ArtificialIntelligence and how #HealthSystems can strive for smarter implementation of #AI tools in their clinical care settings.

This was a great session on AI for CV care at #AHA24 #QCOR24. Learned a lot from Rohan Khera Dhruva Biswas, MD/PhD Phyllis Thangaraj Aline Pedroso Thomas M. Maddox MD. Thanks to Demi Adedinsewo, MD Michael D. Green for moderating and Emily O’Brien Modele Ogunniyi, MD, MPH + QCOR team for putting together the session.

Excited to be at #AHA24 and share the excellent work of our trainees, collaborators, and friends!

AI-based non-invasive assessment of intracardiac filling pressures using CardioTag device accurately estimates PCWP in HFrEF patients, comparable to RHC measurements. Download slides from the SEISMIC-HF study clinicaltrialresults.org/wp-content/upl…

How should we manage #cardiogenicshock in 2024? Come check out #AHA24 session today starting 9:45 AM CT Rm N227AB to learn more abt #phenotyping #teams #Biomarkers #CSWG #CCCTN #AHACS & more! ⁦Sean van Diepen⁩ ⁦venu menon⁩ ⁦BalimSenman⁩ ⁦Jason N. Katz

“The task of interpreting the outputs of AI models cannot be off-loaded to clinicians, especially during a deluge of AI-driven tools that lack adequate controls.” - Rohan Khera Melissa Simon Joseph Ross jamanetwork.com/journals/jama/…

Exciting news just announced at #AHA24: We're investing $12M in artificial intelligence research to drive advancements in cardiovascular and cerebrovascular health. Watch for an RFP in early 2025: spr.ly/6016sip3O

Starting off the final day of #AHA24, Sanjiv J. Shah, (Sanjiv J. Shah, MD), presents the primary results from the ENDEAVOR randomized #ClinicalTrial. #HFpEF AHA Science

Starting soon - don’t miss out! AHA Science

Shoutout to MSAI Fellow Tyler J Smith for creating a python package for Generalizability theory (G-theory). Reliability is always near to our engineer hearts. So when it comes to making statistical inferences from our data it is super important, esp. w.r.t. clinical outcomes

In a recent article, Akhil Narang, MD (Akhil Narang, MD), discusses earlier detection of #HFpEF with the use of #ArtificialIntelligence, which can help change the trajectory of a patient's disease course. onlinejcf.com/article/S1071-…

New multi-center validation in #JACCAdvances compared multiple algorithms for detecting Cardiac #Amyloidosis. EchoGo® Amyloidosis demonstrated the highest sensitivity and accuracy (AUC 0.92). See paper: sciencedirect.com/science/articl… The study highlights the growing role of AI in

We are excited to work with Stanford Department of Medicine, Smidt Heart Institute at Cedars-Sinai, MGH Liver Center, and Kaiser Permanente Research NorCal with the support of American Heart Association to refine and prospectively evaluate AI opportunistic screening approaches for Cardiovascular-Kidney-Metabolic Health! Chronic Liver and Kidney Disease is common